Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-16

FDA Approved: MICROGESTIN 24 FE — Supplemental Application (Mayne Pharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for MICROGESTIN 24 FE, a combined oral contraceptive containing norethindrone acetate/ethinyl estradiol with ferrous fum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MICROGESTIN 24 FE (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL AND FERROUS FUMARATE)

Snippet

SUPPL AP for MICROGESTIN 24 FE (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL AND FERROUS FUMARATE)